In-vitro activity of Ro-15-8074, a new oral cephalosporin
- 1 October 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 16 (4) , 469-473
- https://doi.org/10.1093/jac/16.4.469
Abstract
The in-vitro activity of Ro-15-8074, a new oral cephalosporin, was tested against common clinical isolates, and compared with the in-vitro activity of cefaclor, cefadroxil, ampicillin and co-trimoxazole. Its activity against Enterobacteriaceae was better than those of the other antibiotics tested. It was also highly active against Haemophilus influenzae, including β-lactamase producing strains. Its activity against Pseudomonas aeruginosa and Acinetobacter spp., was poor. Ro-15-8074 was less active against staphylococci and group D streptococci than were cefaclor, cefadroxil and ampicillin. It was equally or less active than cefaclor, cefadroxil, ampicillin and co-trimoxazole against other streptococci.Keywords
This publication has 5 references indexed in Scilit:
- In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporinAntimicrobial Agents and Chemotherapy, 1984
- In vitro activity of U-63196E, a new cephalosporin, against clinical bacterial isolatesAntimicrobial Agents and Chemotherapy, 1984
- In vitro antibacterial activity and beta-lactamase stability of E-0702, a new cephalosporinAntimicrobial Agents and Chemotherapy, 1983
- In vitro activity and beta-lactamase stability of U-63196E, a novel cephalosporinAntimicrobial Agents and Chemotherapy, 1983
- In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamasesAntimicrobial Agents and Chemotherapy, 1980